조혈모세포이식 환자에서 침습성 진균 감염에 대한 Micafungin의 예방 효과 및 안전성
'
조혈모세포이식 환자에서 침습성 진균 감염에 대한 Micafungin의 예방 효과 및 안전성' 의 주제별 논문영향력
| 주제 |
|
|
|---|---|---|
| 동일주제 총논문수 | 논문피인용 총횟수 | 주제별 논문영향력의 평균 |
| 621 | 1 |
0.0% |
주제별 논문영향력
' 조혈모세포이식 환자에서 침습성 진균 감염에 대한 Micafungin의 예방 효과 및 안전성' 의 참고문헌
-
Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantationInt J Hematol 88 : 588 ~ 595 [2008]
-
The spectrum of infection in patients with acute leukemiaKorean J Intern Med 46 : 496 ~ 504 [1985]
-
The changing face of epidemiology of invasive fungal diseases in Europe최희양 [2009]
-
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group전은희 [2008]
-
Pulmonary aspergillosis: early diagnosis improves survival이지선 [1995]
-
Principles and Practice of Infectious Diseases이인숙 [2005]
-
Primary antifungal prophylaxis in leukaemia patients이은화 [2007]
-
Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections신지현 Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis [2008]
-
Micafungin: a new echinocandin신지현 [2006]
-
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial[2007]
-
Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation[2004]
-
Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis신지은 [2007]
-
Laboratory diagnosis of invasive aspergillosis변찬석 [2005]
-
Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B백영애 Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized [2000]
-
Infectious features in patients with acute leukemia박영태 [1999]
-
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective남옥선 [2009]
-
Epidemiology of invasive fungal infections due to Aspergillus spp. and zygomycetes김영채 [2006]
-
Epidemiology of invasive candidiasis: a persistent public health problem김영채 [2007]
-
Echinocandin antifungal drugs김기철 [2003]
-
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus교육과학기술부 [2002]
-
Costeffectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation곽금주 [2008]
-
Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea곽금주 [2009]
-
Comparison of two methods and three end points in determination of in vitro activity of micafungin against Aspergillus spp강성철 [2003]
-
Common Terminology Criteria for Adverse Events v3.0 (CTCAE)
-
Clinical manifestations of graftversus-host disease in human recipients of marrow from HLA-matched sibling donorsWebber [1974]
-
Candidemia in cancer patients: a prospective multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of cancer (EORTC)Stein [1999]
-
Candidaemia in Europe: epidemiology and resistanceSteffy [2006]
-
Aspergillosis case-fatality rate: systematic review of the literatureReigeluth [2001]
-
Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantationRamsden [2009]
-
An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropeniaPang [2006]
-
A method for estimating the probability of adverse drug reactionsLakoff [1981]